Cancer Gene Discovery May Boost Key Drug Class

Cancer Gene Discovery May Boost Key Drug Class

Source: Mirage News

A new study led by scientists at NYU Langone Health sheds light on how the major cancer gene BRCA2 determines which cancer cells can be killed by a

A new study led by scientists at NYU Langone Health sheds light on how the major cancer gene BRCA2 determines which cancer cells can be killed by a class of precision cancer drugs called PARP inhibitors.
Recently published in Nature , the work builds… [5575 chars]

Read more

Leave a Comment

Your email address will not be published.

0